Otsuka Medical Devices announced today that Japanese authorities approved the Recor Medical Paradise ultrasound renal denervation (uRDN) system. Tokyo-based Otsuka's U.S.-based Recor subsidiary developed Paradise for the treatment of resistant hypertension. Recor Medical received a landmark FDA nod for its Paradise system in November 2023. It also … [Read more...] about Recor Medical’s Paradise renal denervation tech wins Japanese approval
Otsuka Holdings
Otsuka partners with ICU Medical to enter U.S. IV products market
Otsuka Holdings will pay ICU Medical (Nasdaq: ICUI) an upfront payment of $200 million as part of a joint venture to enter the U.S. IV products market, which has been facing hurricane-related shortages this fall. The partnership — which involves ICU Medical providing commercial services for Otsuka’s Otsuka Pharmaceutical Factory (OPF) … [Read more...] about Otsuka partners with ICU Medical to enter U.S. IV products market
